During the past decade, NSB Research conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 6 clinical trials were completed, i.e. on average, 35.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 5 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NSB Research" #1 sponsor was "Celgene" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "ModernaTX, Inc." with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NSB Research" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "NSB Research" are "Ulcerative Colitis" (7 trials), "Crohn Disease" (3 trials), "Atrial Fibrillation" (1 trials), "Chronic Kidney Disease" (1 trials) and "Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps" (1 trials). Many other conditions were trialed in "NSB Research" in a lesser frequency.

Most popular intervention types in "NSB Research" are "Drug" (16 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Etrasimod" (4 trials), "Ozanimod" (3 trials), "RPC1063" (2 trials) and "Active Comparator: Licensed IIV IIV will be administered as a single dose intramuscularly on Day 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "NSB Research" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "NSB Research". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in NSB Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NSB Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".